Intranodal immunotherapy (SIIT)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Intranodal immunotherapy (SIIT), covering 2021-03-01 to 2021-03-01. Get the full timeline:
Most recent: Clinical Trial Update: Sequential Intranodal Immunotherapy (SIIT) Combined With Anti-PD1 (Pembrolizumab) in Follicular Lymphoma [Phase 2]